Although there is a large variety of standard treatment strategies for H&NNHL, the internationally recognized treatment is chemotherapy, especially for diffuse large B-cell lymphoma (the commonest high-grade lymphoma) and ALK-negative anaplastic large-cell lymphoma.[23,24] In contrast, patient with other types is not suitable for chemotherapy. The gene discussed is ALK; the disease is diffuse large B-cell lymphoma.